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Prognosticating COVID-19:
A need for Africa-specific laboratory
predictors

CORRESPONDENCE

To the Editor: The rapid spread of SARS-CoV-2 throughout the
world has resulted in significant morbidity and mortality globally. [1]
As of 18 April 2020, there were over 20 000 COVID-19 infections
and over 1 000 deaths in Africa, with more cases being diagnosed
as testing is slowly ramped up.[2] In view of increasing mortality and
scarce critical care resources, there is a need to evaluate the role of
routine laboratory tests in determining which COVID-19 patients
will require critical care and who is likely to survive.
A systematic review by Lippi and Plebani[3] reported that the
common derangements in laboratory tests seen in COVID-19
patients include increased white blood cells, neutrophils, lactate
dehydrogenase (LDH), alanine aminotransferase (ALT), aspartate
aminotransferase (AST), total bilirubin, creatinine, cardiac troponin,
D-dimer, prothrombin time, procalcitonin and C-reactive protein
(CRP), as well as a decrease in lymphocytes and albumin. None of the
included studies was from Africa.
Wang et al.[4] examined the baseline laboratory parameters on the
day of admission in 138 Chinese patients with COVID-19. Significant
differences in median values were noted for several analytes between
patients who needed intensive care unit (ICU) admission and those
who did not. Specifically, patients admitted to an ICU had higher
neutrophils, LDH, ALT, AST, total bilirubin, creatinine, cardiac
troponin I, D-dimer and procalcitonin.
There are currently no publications from Africa describing the
prognostic significance of laboratory tests in predicting severity
of COVID-19, despite evidence that race and ethnicity are known
sources of variation in reference intervals.[5] Karita et al.[6] carried out
a cross-sectional study of healthy adults in Kenya, Uganda, Zambia
and Rwanda from December 2004 to October 2006. Compared with
the USA, they found that the reference interval lower limits for
neutrophils and creatinine were lower in Africans, while upper limits
for total bilirubin, LDH, ALT and AST were higher.[6] Genetic deletion
of the Duffy antigen receptor for chemokines (DARC-null genotype)
is thought to be responsible for the benign neutropenia seen in subSaharan Africa.[7] In several African countries, total bilirubin has
been found to be almost twice the upper limit of that in Caucasians,
while transaminases have also been found to be elevated. [8-10] Chronic
inflammation due to infectious or non-infectious causes may explain
the elevated CRP and IgG levels in sub-Saharan Africa.
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In view of racial and ethnic differences in reference values for some
of the laboratory tests thought to play an important role in COVID19 prognosis as well as the huge burden of infectious diseases such
as HIV, tuberculosis and malaria, there is an urgent need for studies
that can generate clinical and laboratory data to guide the use of
laboratory tests in evaluating and managing COVID-19 patients in
Africa.
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